Drawing for ALTRIKA

USPTO serial 79069921

ALTRIKA

Reviewed by CopyMark Law Group

Reg. 3856875Status 404
Filing date
Status date
Registration date
Oct 5, 2010
Examiner
KING, CHRISTINA B
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALTRIKA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and science, unprocessed artificial resins, unprocessed plastics; adhesives used in industrySECTION 71 - CANCELLED—
005Wound dressing; pharmaceutical preparations for wound care and wound healing; pharmaceutical preparations for treatment of burns, trauma wounds, surgical wounds, acute wounds and chronic wounds such as diabetic foot ulcers, venous ulcers and decubitus ulcers; veterinary preparations for breached skin trauma wounds; materials for dressings, namely, gauze; surgical and wound dressings; pharmaceutical preparations for use in dermatology for the treatment, replacement or repair of skin; surgical and medical implants containing living cells; biological tissue containing living skin cells, namely, products containing autologous human skin cells including keratinocytes and/or fibroblasts and/or melanocytes or products containing good-manufacturing-practice screened allogeneic human keratinocytes or products containing a combination of these autologous or allogenic human skin cells; biological tissue containing living skin replacement products, namely, products containing autologous human skin cells including keratinocytes and/or fibroblasts and/or melanocytes or products containing good-manufacturing-practice screened allogeneic human keratinocytes or products containing a combination of these autologous or allogenic human skin cells; dental composite materials composed of polymers; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; diagnostic preparations for medical purposes composed of polymers; medical adhesives for binding wounds composed of polymersSECTION 71 - CANCELLED—
009Scientific, optical, weighing, measuring, signaling, checking, apparatus and instruments, namely, software for collection of large datasets regarding materials for use in biological applicationsSECTION 71 - CANCELLED—
010Surgical, medical, dental and veterinary apparatus and instruments, namely, polymer films for regeneration of damaged skin; artificial limbs, eyes and teeth; orthopaedic articles, namely, bone substitutes; suture materials; blood filtering apparatus, namely, blood filters; medical and surgical catheters; biodegradable implants consisting of artificial materials; stentsSECTION 71 - CANCELLED—
042Scientific and technological services, namely, design, engineering, research, development and testing services in the field of inorganic, organic, and polymeric materials, inorganic and organic and polymer material synthesis, and materials customization for medical, scientific, and technological applications, and materials testing; scientific research and development services for others in the fields of manipulation of stem cells, culture of human hepatocytes and general cell culture surfaces, use of bioactive surface coatings, the therapeutic use of stem cells, bone substitutes, and topical drug release, handling and processing of blood, including blood banking, clinical diagnostics and, increasingly, the fields of cell therapy and regenerative medicine, treatment of both acute and chronic wounds, and materials used in treating the eyeSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 13, 2019DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Dec 13, 2019DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 28, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 24, 2019CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Nov 22, 2019CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Apr 11, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 29, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 23, 2018INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jan 23, 2018INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jan 23, 2018INPCINVALIDATION PROCESSED—
Jan 12, 2018INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 12, 2017C71TCANCELLED SECTION 71—
Feb 12, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 10, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 6, 2011FIMPFINAL DISPOSITION PROCESSED—
Jan 5, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 5, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 20, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 20, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 14, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 14, 2010ALIEASSIGNED TO LIE—
Jun 12, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Jun 12, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 12, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 12, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
May 21, 2010GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
May 21, 2010GNCFCONTINUATION OF FINAL REFUSAL E-MAILED—
May 21, 2010CNCFACTION CONTINUING A FINAL - COMPLETED—
Apr 23, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 22, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 22, 2010ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 6, 2010GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 6, 2010GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 6, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 30, 2009DOCKASSIGNED TO EXAMINER—
Nov 17, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 17, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 17, 2009ALIEASSIGNED TO LIE—
Nov 4, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 4, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 19, 2009RFNTREFUSAL PROCESSED BY IB—
Aug 14, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 14, 2009RFRRREFUSAL PROCESSED BY MPU—
Aug 14, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 13, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 12, 2009DOCKASSIGNED TO EXAMINER—
Jul 24, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 20, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 17, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance